These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19124557)

  • 1. Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4.
    Zurier RB; Sun YP; George KL; Stebulis JA; Rossetti RG; Skulas A; Judge E; Serhan CN
    FASEB J; 2009 May; 23(5):1503-9. PubMed ID: 19124557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of human monocyte interleukin-1beta production by ajulemic acid, a nonpsychoactive cannabinoid.
    Zurier RB; Rossetti RG; Burstein SH; Bidinger B
    Biochem Pharmacol; 2003 Feb; 65(4):649-55. PubMed ID: 12566094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid.
    Johnson DR; Stebulis JA; Rossetti RG; Burstein SH; Zurier RB
    J Cell Biochem; 2007 Jan; 100(1):184-90. PubMed ID: 16927387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells.
    Stebulis JA; Johnson DR; Rossetti RG; Burstein SH; Zurier RB
    Life Sci; 2008 Nov; 83(19-20):666-70. PubMed ID: 18840450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ajulemic acid, a nonpsychoactive cannabinoid acid, suppresses osteoclastogenesis in mononuclear precursor cells and induces apoptosis in mature osteoclast-like cells.
    George KL; Saltman LH; Stein GS; Lian JB; Zurier RB
    J Cell Physiol; 2008 Mar; 214(3):714-20. PubMed ID: 17786950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis.
    Gonzalez EG; Selvi E; Balistreri E; Akhmetshina A; Palumbo K; Lorenzini S; Lazzerini PE; Montilli C; Capecchi PL; Lucattelli M; Baldi C; Gianchecchi E; Galeazzi M; Pasini FL; Distler JH
    Ann Rheum Dis; 2012 Sep; 71(9):1545-51. PubMed ID: 22492781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.
    Recht LD; Salmonsen R; Rosetti R; Jang T; Pipia G; Kubiatowski T; Karim P; Ross AH; Zurier R; Litofsky NS; Burstein S
    Biochem Pharmacol; 2001 Sep; 62(6):755-63. PubMed ID: 11551521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs.
    Sun YP; Tjonahen E; Keledjian R; Zhu M; Yang R; Recchiuti A; Pillai PS; Petasis NA; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):357-66. PubMed ID: 19853429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid.
    Parker J; Atez F; Rossetti RG; Skulas A; Patel R; Zurier RB
    Rheumatol Int; 2008 May; 28(7):631-5. PubMed ID: 18040689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes.
    József L; Zouki C; Petasis NA; Serhan CN; Filep JG
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13266-71. PubMed ID: 12235371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid.
    Liu J; Li H; Burstein SH; Zurier RB; Chen JD
    Mol Pharmacol; 2003 May; 63(5):983-92. PubMed ID: 12695526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoxin A(4) attenuates zymosan-induced arthritis by modulating endothelin-1 and its effects.
    Conte FP; Menezes-de-Lima O; Verri WA; Cunha FQ; Penido C; Henriques MG
    Br J Pharmacol; 2010 Oct; 161(4):911-24. PubMed ID: 20860668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo.
    Mitchell S; Thomas G; Harvey K; Cottell D; Reville K; Berlasconi G; Petasis NA; Erwig L; Rees AJ; Savill J; Brady HR; Godson C
    J Am Soc Nephrol; 2002 Oct; 13(10):2497-507. PubMed ID: 12239238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells.
    Fierro IM; Colgan SP; Bernasconi G; Petasis NA; Clish CB; Arita M; Serhan CN
    J Immunol; 2003 Mar; 170(5):2688-94. PubMed ID: 12594298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ajulemic acid, a synthetic nonpsychoactive cannabinoid acid, bound to the ligand binding domain of the human peroxisome proliferator-activated receptor gamma.
    Ambrosio ALB; Dias SMG; Polikarpov I; Zurier RB; Burstein SH; Garratt RC
    J Biol Chem; 2007 Jun; 282(25):18625-18633. PubMed ID: 17462987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation.
    Clish CB; Levy BD; Chiang N; Tai HH; Serhan CN
    J Biol Chem; 2000 Aug; 275(33):25372-80. PubMed ID: 10837478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids co-interact with lipoxin A4 via lipoxin A4 receptor (ALX) up-regulation.
    Hashimoto A; Murakami Y; Kitasato H; Hayashi I; Endo H
    Biomed Pharmacother; 2007 Jan; 61(1):81-5. PubMed ID: 17184966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways.
    Prieto P; Cuenca J; Través PG; Fernández-Velasco M; Martín-Sanz P; Boscá L
    Cell Death Differ; 2010 Jul; 17(7):1179-88. PubMed ID: 20094061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4.
    Planagumà A; Pfeffer MA; Rubin G; Croze R; Uddin M; Serhan CN; Levy BD
    Mucosal Immunol; 2010 May; 3(3):270-9. PubMed ID: 20130564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.